✦ LIBER ✦

Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right

✍ Scribed by Tsochatzis, Emmanuel A.; Crossan, Catriona; Longworth, Louise

Book ID: 121843892
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 179 KB
Volume: 61
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2014.04.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to: “Cost-effectiveness of upcomin

Reply to: “Cost-effectiveness of upcoming treatments for hepatitis C: We need to get the models right”

✍ Younossi, Zobair M.; Henry, Linda; Singer, Mendel 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 265 KB

The Impact of Structural Uncertainty on

The Impact of Structural Uncertainty on Cost-Effectiveness Models for Adjuvant Endocrine Breast Cancer Treatments: the Need for Disease-Specific Model Standardization and Improved Guidance

✍ Frederix, Gerardus W. J.; Hasselt, Johan G. C.; Schellens, Jan H. M.; Hövels, An 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 461 KB

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES

✍ Innes, H.A.; Hutchinson, S.J.; Amanda, W.; Dillon, J.F.; Goldberg, D.J.; Mills, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Using competence network collaboration a

Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

✍ Uwe Siebert; Gaby Sroczynski; Jürgen Wasem; Wolfgang Greiner; Ulrike Ravens-Sieb 📂 Article 📅 2005 🏛 Springer 🌐 French ⚖ 261 KB

PIN29 Cost Effectiveness Analysis of Add

PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

✍ Ramachandran, S.; Mahabaleshwarkar, R.; Yang, Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PGI18 Cost-Effectiveness of Boceprevir i

PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)

✍ S.C. Humphreys; E.H. Elbasha; S.A. Ferrante; M. Lion; C. O'Regan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB